Health Care
Price
$45.14
+4.83%Market Cap
$67.09B
Day High
$45.80
Day Low
$43.45
Boston Scientific delivered strong Q1 2026 results with revenue of $5.20B (+11.6% YoY), operating income of $1.10B (+19.5% YoY), and EPS nearly doubling to $0.90, though operating cash flow declined 35.7% to $348M.
Key risk: Operating Cash Flow and Earnings Divergence
Despite nearly doubling EPS to $0.90, operating cash flow declined sharply by 35.7% to $348M. This significant divergence between reported earnings and cash generation may indicate working capital pressures, deferred revenue recognition, or one-time non-cash items boosting net income. Sustained weakness in cash conversion could limit financial flexibility.
Other Health Care Equipment companies